1 Van Damme A, Seront E, Dekeuleneer V, Boon LM, Vikkula M. New and emerging targeted therapies for vascular malformations. Am J Clin Dermatol. 2020;21(5):657–68.
2 International Society for the Study of Vascular Anomalies (ISSVA), Classification of Vascular Anomalies ©2018; available at «
https://www.issva.org/classification» (consulté le 23.10.2021)
3 Lee BB, Baumgartner I, Berlien HP, Bianchini G, Burrows P, Do YS, et al. Consensus document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management. Int Angiol. 2013;32(1):9–36.
4 Frey S, Cantieni T, Vuillemin N, Haine A, Kammer R, von Tengg-Kobligk H, et al. Angioarchitecture and hemodynamics of microvascular arterio-venous malformations. PLoS One. 2018;13(9):e0203368.
5 Lüdi A, Mathys L, Kohl S. Œdème douloureux pulsatile du pouce. Forum Med Suisse. 2021;21(49–50):854–6.
6 Lee KB, Kim DI, Oh SK, Do YS, Kim KH, Kim YW. Incidence of soft tissue injury and neuropathy after embolo/sclerotherapy for congenital vascular malformation. J Vasc Surg. 2008;48(5):1286–91.
7 Yakes W, Huguenot M, Yakes A, Continenza A, Kammer R, Baumgartner I. Percutaneous embolization of arteriovenous malformations at the plantar aspect of the foot. J Vasc Surg. 2016;64(5):1478–82.
8 Park HS, Do YS, Park KB, Kim DI, Kim YW, Kim MJ, et al. Ethanol embolotherapy of hand arteriovenous malformations. J Vasc Surg. 2011;53(3):725–31.
9 Roh YN, Do YS, Park KB, Park HS, Kim YW, Lee BB, et al. The results of surgical treatment for patients with venous malformations. Ann Vasc Surg. 2012;26(5):665–73.
10 Wooderchak-Donahue WL, Johnson P, McDonald J, Blei F, Berenstein A, Sorscher M, et al. Expanding the clinical and molecular findings in RASA1 capillary malformation – arteriovenous malformation. Eur J Hum Genet. 2018;26(10):1521–36.
11 Al-Olabi L, Polubothu S, Dowsett K, Andrews KA, Stadnik P, Joseph AP, et al. Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Invest. 2018;128(11):5185.